| Line 13: |
Line 13: |
| | ===Method=== | | ===Method=== |
| | | | |
| − | Each rat was stereotaxically implanted with a 22 gauge, stainless steel, guide | + | Each rat was stereotaxically implanted with a 22-gauge, stainless steel, guide |
| − | cannula (Plastics One, Roanoke, VA) aimed towards the | + | cannula (Plastics One, Roanoke, VA) aimed towards the lateral cerebral ventricle (1.2 mm caudal to bregma, 1.5 mm |
| − | lateral cerebral ventricle (1.2 mm caudal to bregma, 1.5 mm | + | lateral to the midline, and 4 mm below the skull surface; Houpt 1998 PMID 9437750). Guide cannulas were held in place with dental acrylic bonded to |
| − | lateral to the midline, and 4 mm below the skull surface). | + | stainless steel screws anchored to the skull. An obdurator was inserted into each guide cannula and remained in place |
| − | Guide cannulas were held in place with dental acrylic | + | except during injections when it was removed and replaced with an injector that extended 1.0 mm beyond the tip of the guide cannula. |
| − | bonded to stainless steel screws anchored to the skull. An | |
| − | obdurator was inserted into each guide cannula and remained | |
| − | in place except during injections when it was removed | |
| − | and replaced with an injector that extended 1.0 mm | |
| − | beyond the tip of the guide cannula. | |
| | | | |
| | ===Test=== | | ===Test=== |
| − | To test the patency and placement of the cannula in the lateral ventricle, water-replete rats were injected with 100 ng human angiotensin II (Ang II; Sigma Chemical Co, St Louis, MO) dissolved in 5 µl volume of saline (0.15 M). The volume of all icv injections was 5 µl, delivered over 30s with a handheld 50 µl syringe (Hamilton Co, Reno, NV). Immediately after the ICV injection, rats were returned to their home cage with access to a water bottle. The latency to drink was recorded; rats that failed to drink within 2 minutes of the angiotensin II injection were dropped from the study. Cannula placements were also verified postmortem by sectioning through the brain. ICV injections of 5 µl volume were given by hand to lightly restrained rats using a 50 µl Hamilton microsyringe. | + | To test the patency and placement of the cannula in the lateral ventricle, water-replete rats were injected with |
| | + | 100 ng human angiotensin II (Ang II; Sigma Chemical Co, St Louis, MO) dissolved in 5 µl volume of saline (0.15 M). |
| | + | The volume of all icv injections was 5 µl, delivered over 30s with a handheld 50 µl syringe (Hamilton Co, Reno, NV). |
| | + | Immediately after the ICV injection, rats were returned to their home cage with access to a water bottle. |
| | + | The latency to drink was recorded; rats that failed to drink within 2 minutes of the angiotensin II injection were |
| | + | dropped from the study. Cannula placements were also verified postmortem by sectioning through the brain. |
| | + | ICV injections of 5 µl volume were given by hand to lightly restrained rats using a 50 µl Hamilton microsyringe. |
| | | | |
| | + | ==Fourth Ventricular Cannula:== |
| | | | |
| | + | 3.2 mm caudal to lambda |
| | + | |
| | + | 0 mm lateral to the midline |
| | + | |
| | + | 7.2 mm below the skull surface |
| | + | |
| | + | Plastics One Cannula: |
| | + | |
| | + | ===Method=== |
| | + | Under isoflurane anesthesia, each rat was stereotaxically implanted with a single 22-gauge stainless steel guide cannula |
| | + | (model C315G; Plastics One, Inc., Roanoke, VA) aimed towards the fourth ventricle (4V). The tip of the guide cannula |
| | + | was positioned on the midline 3.2 mm caudal to lambda and 7.2 mm below the skull surface (stereotaxic coordinates |
| | + | taken from (Baird et al. 2009 PMID 19008313)). Guide cannulas were held in place with dental acrylic bonded to stainless |
| | + | steel screws anchored to the skull. An obdurator (model C315DC; Plastics One, Inc.) extending 1.0 mm beyond the guide |
| | + | cannula was inserted into each guide cannula and remained in place except during injections when it was removed and |
| | + | replaced with a XXX-gauge injector that extended 1.0 mm beyond the tip of the guide cannula. |
| | + | |
| | + | ===Test=== |
| | + | To test the patency and placement of the cannula in the lateral ventricle, water-replete rats were injected with |
| | + | XXX ng bombesin (California Peptides) dissolved in 5 µl volume of saline (0.15 M). The volume of all icv injections |
| | + | was 5 µl, delivered by hand over 30s to lightly restrained rats using a 50 µl Hamilton microsyringe (Hamilton Co, Reno, NV). |
| | + | Immediately after the ICV injection, rats were returned to their home cage with access to a water bottle. |
| | + | The latency to initiate and duration of grooming was recorded; rats that failed to groom within 2 minutes of the |
| | + | bombesin injection or groomed for less than XXX minutes were dropped from the study. Cannula placements were |
| | + | also verified postmortem by sectioning through the brain. |
| | | | |
| | | | |